Type
Internal restructuring
Country
Germany
Region
Location of affected unit(s)
Bergkamen, Berlin
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

950 jobs
Number of planned job losses
Job loss
Announcement Date
16 November 2004
Employment effect (start)
Foreseen end date

Description

In the frame of the company strategy of reducing production of pharmaceutical chemicals for third parties, Schering AG plans to cut its contract manufacturing activities at its Bergkamen site with the loss of about 700 jobs. 250 jobs will also be shed at the headquarters in Berlin. About 300 jobs will be cut at sites outside of Germany. In June 2004, Schering announced a headcount reduction of approximately 2,000 jobs globally. By 30 September 2004, more than 600 jobs were cut and about 1,800 of the 2,000 jobs will be cut by the end of 2005. These measures are part of Schering's FOCUS initiative, a comprehensive review of strategic, operational and organizational aspects.


Sources

  • 16 November 2004: Schering - Press release
  • 17 November 2004: Die Welt

Citation

Eurofound (2004), Schering, Internal restructuring in Germany, factsheet number 60814, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60814.